“Benefits and Risks of Testosterone Treatment for Hypoactive Sexual Desire Disorder in Women: A Critical Review of Studies Published in the Decades Preceding and Succeeding the Advent of Phosphodiesterase Type 5 Inhibitors”. Clinics 69, no. 4 (April 1, 2014): 294–303. Accessed May 17, 2024. https://www.revistas.usp.br/clinics/article/view/79512.